THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,012 | -5.7% | 117,318 | +13.2% | 0.01% | +11.1% |
| Q2 2023 | $1,073 | -99.8% | 103,681 | +92.5% | 0.01% | +28.6% |
| Q1 2022 | $515,000 | +372.5% | 53,850 | +264.1% | 0.01% | +600.0% |
| Q3 2021 | $109,000 | -91.7% | 14,791 | -83.7% | 0.00% | -93.3% |
| Q2 2021 | $1,319,000 | +383.2% | 90,864 | +391.9% | 0.02% | +200.0% |
| Q3 2020 | $273,000 | -58.6% | 18,472 | -41.2% | 0.01% | -70.6% |
| Q2 2020 | $659,000 | – | 31,405 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |